FDA Lightens Up on Nictotine Replacement Products
April 1st, 2013 // 4:03 pm @ jmpickett
The Food and Drug Administration is relaxing its restrictions on the use of over-the-counter nicotine patches, gum and lozenges.
Currently, consumers are instructed to stop smoking when they begin using a nicotine replacement product and to stop using it after 12 weeks.
April 3 – Audit Your Lab Like an Expert FDA Auditor: A Roadmap to Lab Compliance
The FDA plans to remove both these restrictions in response to claims by critics that they may cause some smokers to abandon attempts to quit if they have a cigarette while on a replacement therapy.
Allowing people to stay on a nicotine replacement for longer than 12 weeks may increase their chance of quitting, they say.
The FDA said nicotine patches and gum were first approved between 1984 and 1992, while nicotine lozenges and mini-lozenges were approved in 2002-2009.
After reviewing published literature, the agency said it has determined that the concomitant use of cigarettes and other nicotine-containing products “does not raise significant safety concerns.”
Upcoming Expertbriefings.com Webinars 2013
Check out our exclusive FDA drug and device news, too
- April 3 – Audit Your Lab Like an Expert FDA Auditor: A Roadmap to Lab Compliance
- April 10 – Avoid the CDRH eCopy Chaos – How to Prepare a Compliant eCopy Submission
- April 11 – The Quality Manager Gets Fired, the $100,000 Compliance SNAFU, And 21 Tips and Tricks For Your Next Audit
- April 18 – Why You May Want to Move Your Pharma Company to Kansas – 483 and Warning Letter Trends
- April 21 – $500K on Compliance or $300 Million for Consent Decree? – Essential FDA Compliance Tips for Sr Management
- April 30 – FDA Hands Out CAPA 483s Like Candy – Avoid Them With a Closed Loop CAPA SystemÂ
- May 1 – Avoiding Warning Letter Disasters With a Strong Contractor Quality Agreement
- May 7 – FDA Recall Chief Update – How to Design a Bulletproof Product Recall Strategy
